The Hydrolyzed Egg Membrane contains several bacteriolytic enzymes and other components that alter the effect of heat-resistant gram-positive and gram-negative pathogens, increasing the skin's ability to withstand a variety of inflammatory processes. Hydrolyzed Egg Membrane contains very powerful compounds including: a complex of glycosaminoglycans such as glucosamine, chondroitin and hyaluronic acid, elastin, collagen, desmosine, isodesmosine and transforming growth factor-β and other effective compounds. The compounds are proven to be of use for pain management associated with joint disease, due to the distinctive concentration of the potent, natural compounds in the Hydrolyzed Egg Membrane. Therefore in the trial our goal was to examine the effectiveness of this substance on patients with symptoms associated with Osteoarthritis and related inflammatory diseases/conditions which could prove to be far reaching.
For this study we chose 15 patients’ ages 21 years to 80 years (7 males / 8 females) with confirmed joint damage and cartilage injuries, diagnosed with imaging/scoping with low to high pain scales. The optimal dosage administered is 500mg. daily dietary supplement taken with citric juice on an empty stomach.
Significant Scientific Findings of Positive Clinical Responses:
•No patients during the trial voluntarily withdrew or were requested to discontinue the Hydrolyzed Egg Membrane capsules.
•The pain scale before commencement of the trial averaged out at 90% for moderate to severe and 10% for low to moderate pain (based on a scale of 1-10 – 1 being the lowest, 10 being the highest),
•100% of participants could not walk/jog 100 meters without pain occurring in some form.
•100% of participants at times had pain and inflammation following any activities such as sports or brisk walking.
•2 senior participants (> 65 years of age) reported that their mobility increased that led to more independence.
•5 participants with osteoarthritis saw an increase in overall clinical symptoms (pain/mobility/
•2 participants with osteoarthritis reported less pain, more mobility and better range of motion within 10 days into trial .
•Arthritis and amputee participant noted a decrease in inflammation around the distal area of the amputation within 6 days 45% and by 16 days an overall improvement of 65%.
•Participant with the amputation noticed that a chronic (>3 months) ulceration and dermatitis at the operative site of the stump had healed up to 90% at the end of the 30 day trial
•2 participants with post bone fractures and arthritic like symptoms at the break sites noted 60% reduction in pain and associated symptoms.
•1 participant with arthritis and external/internal anatomical damage noted a decrease in site inflammation of 40% and range of motion, pain and general usage increased to 60% by the end of the trial. This individual also had a quality of life improvement by over 50% due to a reduction in her Fibromyalgia
•100% of the participants in the trial patients on some form of analgesic or glucosamine and chondroitin found that in general the oral supplementation of Hydrolyzed Egg Membrane was far superior in treating symptoms of pain and inflammation.
Targeted Clinical Response Results:
Supplementation with Hydrolyzed Egg Membrane produced a significant treatment response at seven days for flexibility (74.5% increase; P = 0.035) and at 30 days for general pain (91.7% reduction; P = 0.006), flexibility (70.6% increase; P = 0.006) and range of motion associated pain (77.3% reduction; P = 0.020). There were no adverse events reported during the study and the treatment was reported to be well tolerated by study participants.
The reporting of results from this human clinical trial demonstrates that Hydrolyzed Egg Membrane is a practical treatment option for the overall management of Joint and Connective Tissue Disease, Symptoms and related superfluous side effects. The study in particular noted an excellent response for participants suffering from Osteoarthritis. A clinical trial dosage of 500 mg taken once per day had a rapid response effect within a 7 day period and over 70% at day 14. The participants’
The ongoing Human Clinical Trial is performed by Morton Scientific Group of Cambridge, Ontario, Canada and overseen by qualified Medical Doctors. Certified Nutraceuticals supplies the world market with kollaGen I.V.X HEM™ in bulk powder which is manufactured at FDA - USDA approved facility and proudly promotes the products as Made in USA.
kollaGen I.V.X-HEM™ powder is 100% hydrolyzed &water soluble, can be made easily into capsules, tablets, beverages, functional foods and cosmetic applications.